ANAB - AnaptysBio, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$83.14
DETAILS
HIGH:
$140.00
LOW:
$50.00
MEDIAN:
$76.00
CONSENSUS:
$83.14
UPSIDE:
39.24%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||
| Revenue | 234.6 | 91.3 | 17.2 | 10.3 | 63.2 | 75 | 8 | 5 | 10 | 16.7 | 17.6 | 15.8 | 5.5 |
| Cost of Revenue | 2.4 | 163.8 | 132.3 | 88.8 | 98.5 | 80.0 | 99.3 | 56.2 | 29.4 | 15.4 | 17.3 | 8.6 | 8.8 |
| Gross Profit | 232.2 | (72.6) | (115.1) | (78.5) | (35.3) | (5.0) | (91.3) | (51.2) | (19.4) | 1.3 | 0.3 | 7.2 | (3.3) |
| Operating Expenses | |||||||||||||
| R&D Expenses | 136.0 | 163.8 | 139.6 | 88.8 | 98.5 | 80.0 | 99.3 | 56.3 | 30.9 | 22.6 | 17.3 | 8.6 | 8.8 |
| SG&A Expenses | 50.7 | 42.4 | 41.9 | 36.6 | 21.5 | 18.9 | 16.1 | 15.5 | 9.3 | 4.3 | 3.6 | 2.4 | 1.9 |
| Other Expenses | (2.4) | (163.8) | (132.3) | (88.8) | (98.5) | (80.0) | (99.3) | (56.3) | (30.9) | (22.6) | (17.3) | (8.6) | 0 |
| Operating Expenses | 184.3 | 42.4 | 49.3 | 36.6 | 21.5 | 18.9 | 16.1 | 15.5 | 9.3 | 4.3 | 3.6 | 2.4 | 1.3 |
| Operating Income | |||||||||||||
| Operating Income | 47.9 | (114.9) | (164.4) | (115.2) | (56.8) | (23.9) | (107.4) | (66.7) | (28.8) | (3.0) | (3.3) | 4.9 | (5.3) |
| Interest Expense | 79.9 | 50.1 | 18.1 | 21.1 | 1.4 | 0 | 1.0 | 1.7 | 1.8 | 0.5 | 0.5 | 1.3 | 0.9 |
| Interest Income | 13.5 | 19.8 | 18.9 | 7.5 | 0.4 | 4.0 | 11.0 | 6.7 | 1.6 | 0 | 0 | 0.0 | 0.0 |
| Profitability | |||||||||||||
| EBITDA | 50.3 | (92.7) | (156.4) | (105.3) | (55.7) | (19.4) | (95.9) | (59.9) | (28.1) | (3.6) | (4.5) | 5.1 | (4.1) |
| EBIT | 47.9 | (95.1) | (157.1) | (107.6) | (57.8) | (19.9) | (96.4) | (60.2) | (28.3) | (3.8) | (4.8) | 4.8 | (4.7) |
| Income Before Tax | (13.1) | (145.2) | (163.6) | (128.7) | (57.8) | (19.9) | (97.5) | (61.8) | (30.1) | (4.3) | (5.3) | 3.5 | (5.5) |
| Income Tax Expense | 0.2 | 0.0 | (0.0) | 0.0 | 0 | 0 | (0.2) | (0.2) | 0 | 0 | 0.1 | 0 | 0 |
| Net Income | (13.2) | (145.2) | (163.6) | (128.7) | (57.8) | (19.9) | (97.3) | (61.7) | (30.1) | (4.3) | (5.4) | 0.2 | (5.5) |
| Per Share Data | |||||||||||||
| EPS (Basic) | -0.46 | -5.12 | -6.08 | -4.57 | -2.11 | -0.73 | -3.60 | -2.50 | -1.52 | -0.23 | -0.38 | 0.25 | -2.28 |
| EPS (Diluted) | -0.46 | -5.12 | -6.08 | -4.57 | -2.11 | -0.73 | -3.60 | -2.50 | -1.52 | -0.23 | -0.36 | 0.24 | -2.23 |
| Shares Outstanding | 27.8 | 28.4 | 26.9 | 28.2 | 27.4 | 27.3 | 27.1 | 24.7 | 19.8 | 2.6 | 2.6 | 37.8 | 1.1 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 238.2 | 123.1 | 36.0 | 71.3 | 495.7 | 250.5 | 171.0 | 113.6 | 81.2 | 51.2 |
| Short-Term Investments | 73.4 | 262.3 | 354.9 | 369.9 | 52.4 | 143.2 | 203.2 | 313.5 | 167.2 | 0 |
| Net Receivables | 33.9 | 40.8 | 6.9 | 1.4 | 0.9 | 0 | 0 | 0.2 | 1.6 | 5.3 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 4.8 | 5.7 | 9.1 | 4.5 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 350.2 | 431.9 | 406.8 | 447.2 | 553.9 | 396.6 | 377.7 | 434.2 | 252.7 | 58.2 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 13.9 | 16.2 | 18.3 | 20.0 | 21.8 | 2.1 | 1.6 | 1.4 | 0.7 | 0.5 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 35.5 | 27.0 | 142.9 | 67.1 | 17.5 | 54.3 | 73.1 | 75.9 | 0.1 |
| Other Non-Current Assets | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 1.5 | 0.2 | 0.1 | 3.4 |
| Total Non-Current Assets | 14.1 | 52.0 | 45.6 | 163.2 | 89.2 | 20.0 | 57.5 | 74.8 | 76.7 | 4.0 |
| Total Assets | 364.4 | 483.8 | 452.4 | 610.4 | 643.1 | 416.6 | 435.2 | 509.0 | 329.4 | 62.2 |
| Current Liabilities | ||||||||||
| Account Payables | 3.9 | 4.0 | 4.7 | 2.8 | 1.7 | 4.2 | 16.2 | 5.4 | 2.3 | 2.3 |
| Short-Term Debt | 2.1 | 0 | 0 | 0 | 0 | 0 | 1.4 | 7.6 | 6.9 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.7 | 4.9 | 3.4 |
| Other Current Liabilities | 32.7 | 39.5 | 23.8 | 5.4 | 4.2 | 3.7 | 2.2 | 2.4 | 1.6 | 1.0 |
| Total Current Liabilities | 38.6 | 45.4 | 37.4 | 26.1 | 16.1 | 19.8 | 29.5 | 21.8 | 14.1 | 5.7 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 12.0 | 353.4 | 0 | 0 | 0 | 0 | 0 | 0.6 | 7.6 | 13.8 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.2) | (0.1) | (0.2) |
| Other Non-Current Liabilities | 276.5 | 0 | 310.8 | 304.4 | 251.1 | 0 | 0 | 0.2 | 0.1 | 3.4 |
| Total Non-Current Liabilities | 288.6 | 367.5 | 326.8 | 322.2 | 270.5 | 0 | 0.7 | 0.8 | 7.7 | 17.2 |
| Total Liabilities | 327.2 | 413.0 | 364.3 | 348.3 | 286.6 | 19.8 | 30.2 | 22.6 | 21.8 | 22.9 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (772.6) | (759.3) | (614.1) | (450.5) | (321.8) | (264.0) | (244.0) | (146.7) | (85.0) | (54.9) |
| Accumulated Other Comprehensive Income | (0.0) | 0.3 | (0.8) | (5.2) | (0.4) | (0.0) | 0.3 | (0.2) | (0.4) | (3.8) |
| Total Stockholders' Equity | 37.2 | 70.9 | 88.1 | 262.1 | 356.4 | 396.7 | 405.0 | 486.4 | 307.6 | 39.3 |
| Total Liabilities & Equity | 364.4 | 483.8 | 452.4 | 610.4 | 643.1 | 416.6 | 435.2 | 509.0 | 329.4 | 62.2 |
| Debt Metrics | ||||||||||
| Total Debt | 14.1 | 369.5 | 17.8 | 19.4 | 21.0 | 0.3 | 2.9 | 8.3 | 14.4 | 13.8 |
| Net Debt | (224.1) | 246.4 | (18.2) | (51.9) | (474.8) | (250.1) | (168.1) | (105.3) | (66.7) | (37.4) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | 49.6 | (145.2) | (163.6) | (128.7) | (57.8) | (19.9) | (97.3) | (61.7) | (30.1) | (4.3) |
| Depreciation & Amortization | 2.4 | 2.4 | 2.4 | 2.3 | 2.1 | 0.6 | 0.5 | 0.3 | 0.2 | 0.2 |
| Stock-Based Compensation | 36.1 | 34.0 | 33.2 | 27.4 | 15.3 | 11.5 | 12.4 | 10.0 | 4.4 | 1.2 |
| Change in Working Capital | (80.7) | (66.3) | (0.3) | 6.8 | (7.5) | (6.8) | 16.9 | 3.5 | 4.1 | (7.0) |
| Other Non-Cash Items | 12.3 | 39.8 | 7.6 | 18.6 | 1.9 | 0.5 | (2.0) | 0.6 | 0.6 | 0.1 |
| Operating Cash Flow | 19.7 | (135.3) | (120.8) | (73.6) | (45.9) | (14.2) | (69.5) | (48.5) | (19.4) | (9.0) |
| Investing Activities | ||||||||||
| Capital Expenditure | (0.1) | (0.4) | (0.8) | (0.4) | (1.4) | (0.6) | (0.8) | (1.1) | (0.3) | (0.1) |
| Acquisitions | 0 | 0 | 0 | 394.5 | 0 | 0 | 0 | 347.5 | 290.9 | 0 |
| Purchases of Investments | (196.4) | (380.4) | (303.9) | (802.5) | (118.7) | (194.9) | (251.8) | (347.5) | (290.9) | 0 |
| Sales/Maturities of Investments | 424.5 | 476.1 | 449.5 | 408.0 | 158.8 | 290.0 | 384.1 | 206.1 | 48.1 | 0 |
| Other Investing Activities | 0 | 0 | 0 | (394.5) | 0.0 | 0 | 0 | (347.5) | (290.9) | 0 |
| Investing Cash Flow | 228.0 | 95.4 | 144.8 | (394.8) | 38.8 | 94.5 | 131.4 | (142.5) | (243.1) | (0.1) |
| Financing Activities | ||||||||||
| Net Debt Issuance | (76.8) | 34.8 | (11.7) | 0 | 0 | (1.4) | (7.5) | (6.9) | 0 | 10 |
| Stock Repurchased | (68.6) | (0.5) | (50) | 0 | 0 | 0 | 0 | 0 | 0 | (0.0) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (1.5) | (8.1) | (0.0) | 32.2 | 249.7 | 0 | 0 | 2.8 | (0.1) | (1.4) |
| Financing Cash Flow | (132.6) | 127.1 | (59.3) | 44.0 | 252.3 | (0.9) | (4.5) | 223.4 | 292.5 | 8.6 |
| Cash Position | ||||||||||
| Net Change in Cash | 115.1 | 87.1 | (35.3) | (424.4) | 245.2 | 79.4 | 57.4 | 32.4 | 30.0 | (0.5) |
| Cash at Beginning | 123.1 | 36.0 | 71.3 | 495.7 | 250.5 | 171.0 | 113.6 | 81.2 | 51.3 | 51.7 |
| Cash at End | 238.2 | 123.1 | 36.0 | 71.3 | 495.7 | 250.5 | 171.0 | 113.7 | 81.2 | 51.2 |
| Free Cash Flow | 19.6 | (135.7) | (121.6) | (74.0) | (47.3) | (14.7) | (70.3) | (49.6) | (19.7) | (9.1) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 234.6 | 91.3 | 17.2 | 10.3 | 63.2 | 75 | 8 | 5 | 10 | 16.7 | 17.6 | 15.8 | 5.5 |
| Gross Profit | 232.2 | (72.6) | (115.1) | (78.5) | (35.3) | (5.0) | (91.3) | (51.2) | (19.4) | 1.3 | 0.3 | 7.2 | (3.3) |
| Operating Income | 47.9 | (114.9) | (164.4) | (115.2) | (56.8) | (23.9) | (107.4) | (66.7) | (28.8) | (3.0) | (3.3) | 4.9 | (5.3) |
| Net Income | (13.2) | (145.2) | (163.6) | (128.7) | (57.8) | (19.9) | (97.3) | (61.7) | (30.1) | (4.3) | (5.4) | 0.2 | (5.5) |
| EPS (Diluted) | -0.46 | -5.12 | -6.08 | -4.57 | -2.11 | -0.73 | -3.60 | -2.50 | -1.52 | -0.23 | -0.36 | 0.24 | -2.23 |
| Balance Sheet | |||||||||||||
| Cash & Equivalents | 238.2 | 123.1 | 36.0 | 71.3 | 495.7 | 250.5 | 171.0 | 113.6 | 81.2 | 51.2 | |||
| Total Assets | 364.4 | 483.8 | 452.4 | 610.4 | 643.1 | 416.6 | 435.2 | 509.0 | 329.4 | 62.2 | |||
| Total Debt | 14.1 | 369.5 | 17.8 | 19.4 | 21.0 | 0.3 | 2.9 | 8.3 | 14.4 | 13.8 | |||
| Stockholders' Equity | 37.2 | 70.9 | 88.1 | 262.1 | 356.4 | 396.7 | 405.0 | 486.4 | 307.6 | 39.3 | |||
| Cash Flow | |||||||||||||
| Operating Cash Flow | 19.7 | (135.3) | (120.8) | (73.6) | (45.9) | (14.2) | (69.5) | (48.5) | (19.4) | (9.0) | |||
| Capital Expenditure | (0.1) | (0.4) | (0.8) | (0.4) | (1.4) | (0.6) | (0.8) | (1.1) | (0.3) | (0.1) | |||
| Free Cash Flow | 19.6 | (135.7) | (121.6) | (74.0) | (47.3) | (14.7) | (70.3) | (49.6) | (19.7) | (9.1) | |||